{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:11:19Z","timestamp":1790291479238,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Left ventricular systolic dysfunction (LVSD) is common following myocardial infarction (MI). Pharmacological management of secondary prevention is known to be sub-optimal. Integration of pharmacists into clinical teams improves prescribing and quantitative outcomes. Few data have been published on patient views of pharmacist input. We aimed to explore patient experiences of attending a dedicated pharmacist independent prescriber (PIP)-led clinic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Semi-structured face-to-face interviews. Participants were aged \u226518\u00a0years with new incident MI and echocardiographically confirmed LVSD. Patients were recruited from three pharmacist-led clinics at point of clinic discharge. Interviews were transcribed verbatim. Thematic analysis was undertaken.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Twelve patients were recruited, median age 67.5\u00a0years and ten male. Six core themes were identified: multidisciplinary working; satisfaction; confidence in the pharmacist; comparative care; prescribing behaviours; and monitoring. Pharmacist clinics complemented other established post-MI services, and participants perceived benefits obtained through effective inter-professional working. Participants welcomed dedicated appointment time, the opportunity to ask questions and address problems. Pharmacist explanations of condition and medicines, prescribing at the point of care and monitoring were beneficial and reduced patient stress.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study demonstrates that a PIP-led post-MI LVSD clinic delivers a positive initial patient experience. More research is needed to understand the longer-term patient experiences, the impact of such models on medication taking behaviours and the experiences of carers and other members of the multidisciplinary team.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/ijpp.12662","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T22:35:01Z","timestamp":1597271701000},"page":"55-60","source":"Crossref","is-referenced-by-count":9,"title":["Patient experiences of pharmacist independent prescriber-led post-myocardial infarction left ventricular systolic dysfunction clinics"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6606-809X","authenticated-orcid":false,"given":"Iain A","family":"Speirits","sequence":"first","affiliation":[{"name":"Pharmacy Services, NHS Greater Glasgow & Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-5571","authenticated-orcid":false,"given":"Anne C","family":"Boyter","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0719-7614","authenticated-orcid":false,"given":"Emma","family":"Dunlop","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Gray","sequence":"additional","affiliation":[{"name":"Pharmacy Services, NHS Greater Glasgow & Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynsey","family":"Moir","sequence":"additional","affiliation":[{"name":"Pharmacy Services, NHS Greater Glasgow & Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3804-6795","authenticated-orcid":false,"given":"Paul","family":"Forsyth","sequence":"additional","affiliation":[{"name":"Pharmacy Services, NHS Greater Glasgow & Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"2021021707520082500_CIT0001","author":"World Health organisation","year":"2008"},{"key":"2021021707520082500_CIT0002","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/heartjnl-2015-307516","article-title":"The epidemiology of cardiovascular disease in the UK 2014","volume":"101","author":"Bhatnagar","year":"2015","journal-title":"Heart"},{"key":"2021021707520082500_CIT0003","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(13)62070-X","article-title":"Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK","volume":"383","author":"Sheng-Chia","year":"2014","journal-title":"Lancet"},{"key":"2021021707520082500_CIT0004","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ehj.2004.08.006","article-title":"An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry","volume":"25","author":"Velazquez","year":"2004","journal-title":"Eur Heart J"},{"key":"2021021707520082500_CIT0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000054165.93055.42","article-title":"Prevention of heart failure in patients in the heart outcomes prevention evaluation (HOPE) study","volume":"107","author":"Arnold","year":"2003","journal-title":"Circulation"},{"key":"2021021707520082500_CIT0006","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2021021707520082500_CIT0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003045","article-title":"Predicting outcomes over time in patients with heart failure, left ventricular systolic dysfunction, or both following acute myocardial infarction","volume":"5","author":"Lopes","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2021021707520082500_CIT0008","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/imj.12102","article-title":"Mortality, morbidity and evidence-based management amongst patients in regional New Zealand with severe left ventricular systolic dysfunction (1197\u20132011)","volume":"43","author":"Grainger","year":"2013","journal-title":"Intern Med J"},{"key":"2021021707520082500_CIT0009","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jcpt.12367","article-title":"Pharmacist-involved care for patients with heart failure and acute coronary syndrome: a systematic review with qualitative and quantitative meta-analysis","volume":"41","author":"Kang","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"2021021707520082500_CIT0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2019-000676","article-title":"Improving medication optimisation in left ventricular systolic dysfunction after acute myocardial infarction","volume":"8","author":"Forsyth","year":"2019","journal-title":"BMJ Open Qual"},{"key":"2021021707520082500_CIT0011","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000921","article-title":"Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model","volume":"5","author":"Khatib","year":"2018","journal-title":"Open Heart"},{"key":"2021021707520082500_CIT0012","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11096-013-9889-2","article-title":"Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure","volume":"36","author":"Lowrie","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"2021021707520082500_CIT0013","author":"National Health Service Greater Glasgow and Clyde"},{"key":"2021021707520082500_CIT0014"},{"key":"2021021707520082500_CIT0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"2021021707520082500_CIT0016"},{"key":"2021021707520082500_CIT0017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"key":"2021021707520082500_CIT0018","author":"Saks","year":"2013"},{"key":"2021021707520082500_CIT0019","author":"Newton","year":"2010"},{"key":"2021021707520082500_CIT0020","author":"Royal Pharmaceutical Society"},{"key":"2021021707520082500_CIT0021","author":"Royal Pharmaceutical Society"},{"key":"2021021707520082500_CIT0022","author":"National Institute for Health and Clinical Excellence","year":"2015"},{"key":"2021021707520082500_CIT0023","author":"Scottish School of Primary Care"},{"key":"2021021707520082500_CIT0024","author":"Department of Health"},{"key":"2021021707520082500_CIT0025","author":"Royal Pharmaceutical Society"},{"key":"2021021707520082500_CIT0026","author":"Latter","year":"2010"},{"key":"2021021707520082500_CIT0027","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1211\/ijpp.17.02.0003","article-title":"Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation","volume":"17","author":"Stewart","year":"2009","journal-title":"Int J Pharm Pract"},{"key":"2021021707520082500_CIT0028","author":"International Pharmaceutical Federation","year":"2010"},{"key":"2021021707520082500_CIT0029","author":"World Health Organisation","year":"2010"},{"key":"2021021707520082500_CIT0030","author":"Piepoli","year":"2015"},{"key":"2021021707520082500_CIT0031","author":"Scottish intercollegiate Guideline Network (SIGN)","year":"2017"},{"key":"2021021707520082500_CIT0032","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jacc.2004.12.005","article-title":"The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioural cardiology","volume":"45","author":"Rozanski","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2021021707520082500_CIT0033","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2021021707520082500_CIT0034","author":"National Institute for Health and Clinical Excellence","year":"2013"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijpp.12662","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijpp.12662","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijpp.12662","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/29\/1\/55\/36291505\/ijpp12662.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/29\/1\/55\/36291505\/ijpp12662.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T08:47:26Z","timestamp":1613810846000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/29\/1\/55\/6025211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,30]]},"published-print":{"date-parts":[[2021,2,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ijpp.12662","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,7,30]]}}}